Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Agimexpharm Pharmaceutical JSC's Enterprise Value for Today is ₫0.00 Mil.
Agimexpharm Pharmaceutical JSC (HSTC:AGP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Agimexpharm Pharmaceutical JSC Market Cap Related Terms
Agimexpharm Pharmaceutical JSC Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agimexpharm Pharmaceutical JSC Market Cap Chart
Agimexpharm Pharmaceutical JSC Annual Data
Trend
Market Cap
Agimexpharm Pharmaceutical JSC Semi-Annual Data
Market Cap
HSTC:AGP vs : Market Cap Comparison
For the Drug Manufacturers - General subindustry, Agimexpharm Pharmaceutical JSC's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agimexpharm Pharmaceutical JSC Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Agimexpharm Pharmaceutical JSC's Market Cap distribution charts can be found below:
* The bar in red indicates where Agimexpharm Pharmaceutical JSC's Market Cap falls into.
Agimexpharm Pharmaceutical JSC Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a Market Cap of ₫0.00 Mil as of Jul. 23, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. According to the industry distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 1023 companies in the Drug Manufacturers industry.
Is Agimexpharm Pharmaceutical JSC's Market Cap too high?
Agimexpharm Pharmaceutical JSC's current Market Cap is ₫0.00 Mil. Based on the distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 1023 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Agimexpharm Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Agimexpharm Pharmaceutical JSC's Market Cap compare to ?
According to the Drug Manufacturers industry distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 1023 companies for Market Cap. This places Agimexpharm Pharmaceutical JSC in the lower half of its industry. The industry median Market Cap is 211.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 211.56, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Market Cap is 211.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agimexpharm Pharmaceutical JSC's current Market Cap is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agimexpharm Pharmaceutical JSC stock overvalued right now?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a current Market Cap of ₫0.00 Mil. The current Market Cap is ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Agimexpharm Pharmaceutical JSC (HSTC:AGP), the current Market Cap is ₫0.00 Mil as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Agimexpharm Pharmaceutical JSC Business Description
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
13GF Score
Get the complete analysis for HSTC:AGP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:AGP has been successfully added to your 
